135 related articles for article (PubMed ID: 1598741)
1. ABO and rhesus blood groups as prognostic factors in transitional cell carcinomas of the upper urinary tract.
Krogh J; Kvist E
Urol Int; 1992; 48(1):9-13. PubMed ID: 1598741
[TBL] [Abstract][Full Text] [Related]
2. Blood groups and urothelial tumours of the upper urinary tract. A study of 295 patients.
Kvist E; Krogh J; Rye B
Scand J Urol Nephrol; 1990; 24(4):253-5. PubMed ID: 2125744
[TBL] [Abstract][Full Text] [Related]
3. Urothelial tumours of the upper urinary tract.
Kirkali Z; Moffat LE; Deane RF; Kyle KF; Graham AG
Br J Urol; 1989 Jul; 64(1):18-24. PubMed ID: 2765765
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract.
Lee SE; Hong SK; Han BK; Yu JH; Han JH; Jeong SJ; Byun SS; Park YH; Choe G
Jpn J Clin Oncol; 2007 Jan; 37(1):49-55. PubMed ID: 17204506
[TBL] [Abstract][Full Text] [Related]
6. The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
Rink M; Engel O; Gakis G; Fritsche HM; Vetterlein MW; Soave A; Peine S; Aziz A; Dahlem R; Stenzl A; Burger M; Shariat SF; Fisch M; Gild P
Urol Oncol; 2017 Dec; 35(12):671.e17-671.e23. PubMed ID: 28889922
[TBL] [Abstract][Full Text] [Related]
7. The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
Engel O; Soave A; Peine S; Kluth LA; Schmid M; Shariat SF; Dahlem R; Fisch M; Rink M
World J Urol; 2015 Nov; 33(11):1769-76. PubMed ID: 25782867
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
11. ErbB2, ErbB3 and ErbB4 expression in urothelial tumors of the upper urinary tract and their prognostic significance.
Galanakis I; Spyropoulos E; Gkialas I; Nomikos A; Souka E; Mitropoulos D
J BUON; 2013; 18(3):653-9. PubMed ID: 24065479
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma.
Kim M; Moon KC; Choi WS; Jeong CW; Kwak C; Kim HH; Ku JH
World J Urol; 2015 Oct; 33(10):1439-57. PubMed ID: 25600022
[TBL] [Abstract][Full Text] [Related]
14. Relationship between blood groups and tumors of the upper urinary tract.
Kvist E; Lauritzen AF; Bredesen J; Luke M
Scand J Urol Nephrol; 1988; 22(4):289-91. PubMed ID: 3238334
[TBL] [Abstract][Full Text] [Related]
15. Upper urinary tract cancer: location is correlated with prognosis.
van der Poel HG; Antonini N; van Tinteren H; Horenblas S
Eur Urol; 2005 Sep; 48(3):438-44. PubMed ID: 16115524
[TBL] [Abstract][Full Text] [Related]
16. CEA and ABO(H) in upper urinary tract transitional tumors.
Dalla Palma P; Parenti A; Poletti A
Appl Pathol; 1984; 2(3):146-52. PubMed ID: 6399981
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M
J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
19. Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test?
Chow NH; Tzai TS; Cheng HL; Chan SH; Lin JS
Urol Int; 1994; 53(1):18-23. PubMed ID: 7974880
[TBL] [Abstract][Full Text] [Related]
20. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
Murshidi MS
Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
